| COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas | Cell | 2021 | 150 |
| Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study | Lancet, The | 2021 | 103 |
| MO1043EXPLORATION OF REMOTE SCIENTIFIC RESEARCH TRAINING FOR MEDICAL STUDENTS DURING THE COVID-19 PANDEMIC | Nephrology Dialysis Transplantation | 2021 | 78 |
| In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs | Cell | 2021 | 61 |
| Novel Canine Coronavirus Isolated from a Hospitalized Pneumonia Patient, East Malaysia | Clinical Infectious Diseases | 2021 | 49 |
| Prevalence of Comorbid Asthma and Related Outcomes in COVID-19: A Systematic Review and Meta-Analysis | Journal of Allergy and Clinical Immunology: in Practice | 2021 | 47 |
| Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications | Nature Communications | 2021 | 46 |
| Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2 | International Journal of Biological Macromolecules | 2021 | 39 |
| SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation | Cellular and Molecular Immunology | 2021 | 39 |
| Charge-reversal biodegradable MSNs for tumor synergetic chemo/photothermal and visualized therapy | Journal of Controlled Release | 2021 | 39 |
| One year of SARS-CoV-2 evolution | Cell Host and Microbe | 2021 | 34 |
| Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study | Emerging Microbes and Infections | 2021 | 32 |
| The main bioactive compounds of Scutellaria baicalensis Georgi. for alleviation of inflammatory cytokines: A comprehensive review | Biomedicine and Pharmacotherapy | 2021 | 31 |
| The mA methylome of SARS-CoV-2 in host cells | Cell Research | 2021 | 28 |
| Smart materials for drug delivery and cancer therapy | View | 2021 | 25 |
| A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques | Emerging Microbes and Infections | 2021 | 25 |
| VFDB 2022: a general classification scheme for bacterial virulence factors | Nucleic Acids Research | 2021 | 24 |
| Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19): A Post hoc Analysis of LOTUS China Trial | Clinical Infectious Diseases | 2021 | 24 |
| Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12) | Journal of Thoracic Oncology | 2021 | 24 |
| Nano-herb medicine and PDT induced synergistic immunotherapy for colon cancer treatment | Biomaterials | 2021 | 23 |
| The architecture of the SARS-CoV-2 RNA genome inside virion | Nature Communications | 2021 | 23 |
| Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial | JAMA Oncology | 2021 | 23 |
| Clinical management and treatment of obesity in China | Lancet Diabetes and Endocrinology,the | 2021 | 22 |
| Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial | Journal of Clinical Oncology | 2021 | 22 |
| T cell antigen discovery | Nature Methods | 2021 | 21 |
